Navigation Links
Why some experimental forms of 'The Pill for Males' will never rise to the occasion

It appears that "The Pill" for men will have to wait a while longer. A new research report published in the June 2014 issue of The FASEB Journal involving mice, shows that a previously developed male hormonal oral contraceptive method (i.e. via testosterone) is unable to stop the production and / or the release of sperm.

"Our research in mice explains why the efficacy of male hormonal contraception is not as effective as expected and it provides clues on how to improve the method," said Ilpo Huhtaniemi, M.D., Ph.D., M.D.hc, FMed.Sci., a researcher involved in the work from the Institute of Reproductive and Developmental Biology at the Imperial College of London in London, UK.

Scientists demonstrated in experimental mice that the male contraception approach by testosterone has an inherent problemspermatogenesis does not stop. They found that that administering increasing doses of testosterone to infertile mutant mice did allow sexual function to return at a certain dosing threshold, which was expected. What was not expected, however, is that spermatogenesis also returned at that dose. This suggests that it is impossible to give a single dose of testosterone that allows for sexual function and the suppression of pituitary gonadotropin secretion, but also does not initiate sperm production.

"Ever since The Pill was developed, we've been aiming for an equivalent for men," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "This report suggests that we may be finally reaching the end of administering testosterone for this purpose."


Contact: Cody Mooneyhan
Federation of American Societies for Experimental Biology

Page: 1

Related medicine news :

1. Experimental Chemo Combo for Colon Cancer Disappoints
2. Experimental Pill for Multiple Sclerosis Shows Promise
3. Experimental Gel May Help Those With Advanced Parkinsons
4. Experimental Drug Eases Autistic Behaviors in Mice
5. Experimental Drug Helps Fight Some Childhood Cancers, Study Finds
6. Experimental drug improves muscle strength among male cancer patients
7. Experimental Vaccine Seems to Stop Nicotine Addiction in Mice
8. Content Writing King Announces Cancellation Of Experimental Video Creation Process For Their Article Marketing Website
9. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
10. Experimental drug may extend therapeutic window for stroke
11. Experimental Chemical Helps Blind Mice See
Post Your Comments:
(Date:11/24/2015)... ... ... Bibliomotion is thrilled to announce the launch of UNCONVENTIONAL ... Nancy M. Schlichting, Chief Executive Officer of Henry Ford Health System (November ... of patients and their families, shaped my desire to improve the system of care. ...
(Date:11/24/2015)... FL (PRWEB) , ... November 24, 2015 , ... ... and engineer of patented products, announces Innovative Blending, a household invention that revolutionizes ... , "The Juice & Smoothie Bars market is worth $2 billion," says Scott ...
(Date:11/24/2015)... ... 2015 , ... World Patent Marketing , a vertically ... invention which offers a combination of natural essential oils to create something fragrantly ... $3 billion annually," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:11/24/2015)... ... , ... “I am so thrilled, as a newbie here, to leave a mark for the ... School Lounge Makeover® from California Casualty . Stephanie is in her fifth year teaching ... longer tenure. , “This is such an amazing school and we deserve a space where ...
(Date:11/24/2015)... ... November 24, 2015 , ... There’s nothing better than giving the gift of ... can enjoy. , This year, gardens are popping up in the most unexpected ... , Vita Gardens’ African Keyhole Garden Bed ($499) , Water conscious gardeners – ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Calif. , Nov. 24, 2015 Abaxis, ... manufacturing point-of-care instruments and consumables for the medical, research, ... Taylor , Chief Financial Officer, will present at the ... Tuesday, December 1, 2015 at 11:30 a.m. ET. The ... Palace in New York City . ...
(Date:11/24/2015)... Nov. 24, 2015   Mast Therapeutics, Inc. ... molecular adhesion and sealant technology (MAST) platform to develop ... stroke, today announced that the Company,s Chief Executive Officer, ... Piper Jaffray 27 th Annual Healthcare Conference on ... the New York Palace hotel in New ...
(Date:11/24/2015)... DIEGO , Nov. 24, 2015 Arena Pharmaceuticals, ... scheduled to present a corporate overview and update at the ... December 2, 2015, at 8:30 a.m. Eastern Time (5:30 a.m. ... New York City . . ... days following the event. Please connect to Arena,s website several ...
Breaking Medicine Technology: